1 |
Wei X-Q, Li X, Xin X-J,et al (2013). Clinical features and survival analysis of very young (age<35) breast cancer patients. Asian Pac J Cancer Prev, 14, 5949-52.
DOI
ScienceOn
|
2 |
Weiss A, Noorbaksh A, Tokin C, et al (2013). Hormone receptornegative breast cancer: undertreatment of patients over 80. Ann Surg Oncol, 20, 3274-8.
DOI
|
3 |
Yoshida M, Shimizu C, Fukutomi T, et al (2011). Prognostic factors in young Japanese women with breast cancer : prognostic value of age at diagnosis. Jpn J Clin Oncol, 41, 180-9.
DOI
|
4 |
Aapro M, Wildiers H (2012). Triple-negative breast cancer in the older population. Ann Oncol, 23, 52-5.
DOI
|
5 |
Acevedo F, Sanchez C, Jans J, et al (2014). How much survival benefit is necessary for breast cancer patients to opt for adjuvant chemotherapy? results from a Chilean survey. Ecancermedicalscience, 8, 391.
|
6 |
Adami H, Malker B, Meirik O, et al (1985). Age as a prognostic factor in breast cancer. Cancer, 56, 898-902.
DOI
|
7 |
Anders C, Johnson R, Litton J, et al (2009). Breast cancer before age 40 years. Sem Oncol, 36, 237-49.
DOI
ScienceOn
|
8 |
Berry D, Cronin K, Plevritis S, et al (2005). Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med, 353, 1784-92.
DOI
|
9 |
Bastiaannet E, Liefers G , de Craen J, et al (2010). Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients. Breast Cancer Res Treatment, 124, 801-7.
DOI
|
10 |
Bastiaannet E, Portielje J, van de Velde C, et al (2011). Lack of survival gain for elderly women with breast cancer. Oncologist, 16, 415-23.
DOI
|
11 |
Biganzoli L, Wildiers H, Oakman C, et al (2012). Management of elderly patients with breast cancer: updated recommendations of the international society of geriatric oncology (SIOG) and European society of breast cancer specialists (EUSOMA). Lancet Oncol, 13, 148-60.
DOI
|
12 |
Bouchardy C, Rapiti E, Fioretta G, et al (2003). Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol, 21, 3580-7.
DOI
|
13 |
Champion V. (1992). Breast self-examination in women 65 and older. J Gerontol, 47, 75-9.
DOI
|
14 |
Cianfrocca M, Goldstein L (2004). Prognostic and predictive factors in early-stage breast cancer. Oncology, 9, 606-16.
DOI
|
15 |
Colak D, Nofal A, Albakheet A, et al (2013). Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women. PloS One, 8, 63204.
DOI
|
16 |
Diab S, Elledge R, Clark G (2001). Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst, 93, 65-6.
|
17 |
Gennari R, Curigliano G, Rotmensz N, et al (2004). Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients. Cancer, 101, 1302-10.
DOI
|
18 |
Elkin E, Hurria A, Mitra N, et al (2006). Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort. J Clin Oncol, 24, 2757-64.
DOI
|
19 |
Elston C, Ellis I (1991). Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow up. Histopathology, 19, 403-10.
DOI
|
20 |
Fisher C, Egan M, Smith P, et al (1997). Histopathology of breast cancer in relation to age. Br J Cancer, 75, 593-6.
DOI
|
21 |
Gnerlich J, Deshpande A, Jeffe D, et al (2009). Elevated breast cancer mortality in young women (<40 Years) compared with older women is attributed to poorer survival in early stage disease. J Am College Surgeons, 208, 341-7.
DOI
ScienceOn
|
22 |
Goldhirsch A, Ingle J, Gelber R, et al (2009). Thresholds for therapies: highlights of the St gallen international expert consensus on the primary therapy of early breast cancer 2009. Ann Oncol, 20, 1319-29.
DOI
|
23 |
Goldhirsch A, Winer E, Coates S, et al (2013). Personalizing the treatment of women with early breast cancer: highlights of the St gallen international expert consensus on the primary therapy of early breast cancer 2013. Ann Oncol, 24, 2206-23.
DOI
ScienceOn
|
24 |
Goldhirsch A, Wood W, Gelber R, et al (2007). Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol: Official J European Soc Med Oncol/ESMO, 18, 1133-44.
DOI
|
25 |
Louwman W, Vulto J, Verhoeven R, et al (2007). Clinical epidemiology of breast cancer in the elderly. European J Cancer (Oxford, England: 1990), 43, 2242-52.
DOI
|
26 |
Hanson L, Muss H (2010). Cancer in the oldest old: making better treatment decisions. J Clin Oncol: Official J Am Soc Clin Oncol, 28, 1975-6.
DOI
|
27 |
Kissal A, Beser A (2011). Knowledge , facilitators and perceived barriers for early detection of breast cancer among elderly Turkish women. Asian Pac J Cancer Prev, 12, 975-84.
|
28 |
Kroman N, Jensen M, Wohlfahrt J, et al (2000). Factors influencing the effect of age on prognosis in breast cancer: population based study. BMJ (Clin Res Ed.), 320, 474-8.
DOI
|
29 |
Memon Z, Shaikh A, Rizwan S, et al (2013). Reasons for patient's delay in diagnosis of breast carcinoma in Pakistan. Asian Pac J Cancer Prev, 14, 7409-14.
DOI
ScienceOn
|
30 |
Morrison D, Rahardja D, King E, et al (2012). Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer. British J Cancer, 107, 382-7.
DOI
|
31 |
Morrow M (1994). Breast disease in elderly women. Surg Clinic North Am, 74, 145-61.
DOI
|
32 |
Nixon J, Neuberg D, Hayes D, et al (1994). Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol: Official J Am Soc Clin Oncol, 12, 888-94.
DOI
|
33 |
Oran E, Yankol Y, Soybir G, et al (2014). Distinct postsurgical management in young and elderly breast cancer patients results in equal survival rates. Asian Pac J Cancer Prev, 15, 7843-7.
DOI
|
34 |
Siegel R, Ma J, Zou Z, et al (2014). Cancer Statistics, 2014, 64, 9-29.
DOI
|
35 |
Ring A, Harder H, Langridge C, et al (2013). Adjuvant chemotherapy in elderly women with breast cancer (AChEW): an observational study identifying MDT perceptions and barriers to decision making. Ann Oncol, 24, 1211-9.
DOI
|
36 |
Roder D, Silva P, Zorbas H, et al (2012). Adherence to recommended treatments for early invasive breast cancer: decisions of women attending surgeons in the breast cancer audit of Australia and New Zealand. Asian Pac J Cancer Prev, 13, 1675-82.
DOI
ScienceOn
|
37 |
Schonberg M, Marcantonio E, Li D, et al (2010). Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol, 28, 2038-45.
DOI
|
38 |
Singh R, Hellman S, Heimann R (2004). The natural history of breast carcinoma in the elderly: implications for screening and treatment. Cancer, 100, 1807-13.
DOI
|
39 |
U.S. Preventive Services Task Force. (2009). Screening for breast cancer: U.S. preventive services task force recommendation statement. Ann Intern Med, 151, 716-26.
DOI
|
40 |
Van Leeuwen B, Rosenkranz K, Feng L, et al (2011). The effect of under-treatment of breast cancer in women 80 years of age and older. Crit Rev Oncol/hematol, 79, 315-20.
DOI
|
41 |
Vinh-Hung V, Joseph S, Coutty N, et al (2010). Age and axillary lymph node ratio in postmenopausal women with T1-T2 node positive breast cancer. Oncolog, 15, 1050-62.
DOI
|
42 |
Vollmer R (1996). Younger women with breast carcinoma have a poorer prognosis than older women. Cancer, 78, 1518-9.
DOI
|